LCG Wins Position on $30 Million Blanket Purchase Agreement with National Institute on Drug Abuse

LCG to provide information technology research, application, and web development support services

ROCKVILLE, Md. (November 3, 2014) – LCG, a leading provider of innovative grants management and technology solutions to federal agencies, today announced that it has been awarded a position on a blanket purchase agreement (BPA) by the National Institute on Drug Abuse (NIDA) to provide information technology research, application, and web development support services to customers at the National Institutes of Health (NIH). The contract has a $30 million ceiling over a five year period.

LCG will provide the expertise and solutions needed to develop and sustain integrated technologies that further the scientific research conducted by NIH institutions. Under the terms of the BPA, NIH customers will be able to quickly and efficiently leverage LCG and its partners -- Akimeka, Engility, and KGS -- for support in operation and maintenance, information security, application and web development, scientific computing and programming, and business analysis.

“For more than 15 years, LCG has provided institutions at the NIH with the solutions and services required to meet the their complex technology needs," said LCG chief operating officer Raymond C. Tye, "This award highlights LCG's unique understanding and expertise of the systems, operating environment, and research priorities required for the NIH to achieve its mission of improving public health."

As the world’s leading medical research agency, the NIH is responsible for seeking fundamental knowledge about the nature and behavior of living things, and applying that knowledge to enhance public health, improve length of life, and reduce disease and disability. As an institution at the NIH, the NIDA is responsible for conducting research across a range of disciplines, while also ensuring that results are rapidly and effectively distributed to help improve both the prevention and treatment of drug abuse and addiction. LCG has a long history of supporting the NIH and its institutions by implementing innovative technology and management solutions that maintain the complex technological infrastructure and operational environment, enabling some of the world’s preeminent scientific research.

About LCG:

LCG is a Rockville, Maryland based company with operations in Arlington, Virginia that provides end-to-end grants management, technology solutions, and scientific research support to federal agencies. Since 1990, LCG has consistently developed solutions to make processes, operations, and outcomes more efficient and flexible, and deliver unique innovations to better performance. For more information, visit